DOI: http://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20194563

A retrospective clinicopathological study of cases of perforating dermatoses in a tertiary care centre

Saradha Kandasamy, Prathiba Subramanian, Geetharani Gopalan, Ashwini Krishnamoorthy

Abstract


Background: Perforating deramtoses is a group of diseases characterized by extrusion of dermal materials such as inflammatory cells or extracellular substances through the epidermis. They can be classified as primary and secondary perforating dermatoses. This study was done to assess the prevalence and associated systemic diseases of perforating dermatoses in our setting.

Methods: This is a retrospective study done by reviewing the hospital records of patients who attended the skin OPD, Government Rajaji Hospital, Madurai Medical College, Madurai during the period June 2008 to June 2010. All patients diagnosed clinically as perforating dermatoses and supported by histopathological examination were included.

Results: Kyrle’s disease (54%) was the commonest type, followed by reactive perforating collagenosis (43%) and perforating calcific elastosis (3%). About 53% of the patients presented as hyperkeratotic papules and 43% as hyperkeratotic, plugged, umbilicated papules and plaques. Erythematous papules arranged in annular and serpiginous pattern in the periphery of the central atrophic plaques were noted in 1 patient (3%). Lower extremities (73%) were the most commonly involved site. (67%) patients had at least one systemic disease and commonest association was diabetes mellitus (53%), chronic renal failure (36%), hypothyroidism (3%).

Conclusions: Perforating dermatoses is a uncommon dermatological condition characterized by Trans Epidermal Elimination of dermal substances. Since it has a strong association with systemic diseases screening for systemic diseases is required for all cases.


Keywords


Transepidermal elimination, Primary, Secondary, Extremities, Systemic associations

Full Text:

PDF

References


Burrows NP, Lovell CR. Disorders of connective tissue. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s Textbook of Dermatology. 7th ed. Massachusetts: Blackwell Sci; 2004: 64-67.

Pedragosa R, Knobel HJ, Huguet P, Oristrell J, Valdés M, Bosch JA. Reactive perforating collagenosis in Hodgkin's disease. Am J Dermatopathol. 1987;9:41-4.

Henry JC, Jorizzo JL, Apisarthanarax P. Reactive perforating collagenosis in the setting of prurigo nodularis. Int J Dermatol. 1983;22:386-7.

Faver IR, Daoud MS, Su WP. Acquired reactive perforating collagenosis. Report of six cases and review of the literature. J Am Acad Dermatol. 1994;30(4):575-80.

Bank DE, Cohen PR, Kohn SR. Reactive perforating collagenosis in a setting of double disaster: acquired immunodeficiency syndrome and end stage renal disease. J Am Acad Dermatol. 1989;21:371-4.

Zelger B, Hintner H, Auböck J, Fritsch PO. Acquired perforating dermatosis: Transepidermal elimination of DNA material and possible role of leukocytes in pathogenesis. Arch Dermatol. 1991;127(5):695-700.

Kim JH, Kang WH. Acquired reactive perforating collagenosis in a diabetic patient with pulmonary aspergillosis. Cutis. 2000;66:425-30.

Thiele-Ochel S, Schneider LA, Reinhold K, Hunzelman N, Krieg T, Scharffetter- Kochanek K. Acquired perforating collagenosis:is it due to damage by scratching? Br J Dermatol. 2001;145:173-4.

Hinrichs W, Breuckmann F, Altmeyer P, Kreuter A. Acquired perforating dermatosis: a report on 4 cases associated with scabies infection. J Am Acad Dermatol. 2004;51:665-7.

Rapini RP, Hebert AA, Drucker CR. Acquired perforating dermatoses. Evidence for combined transepidermal elimination of both collagen and elastic fibers. Arch Dermatol. 1989;125:1074.

Saray Y, Seckin D, Bilezikci B. Acquired perforating dermatosis: clinicopathological features in twenty two cases. J Eur Acad Dermatol Venereol. 2006;20(6):679-88.

Rapini RP. Perforating diseases. In: Bolognia JL, Jorizzo JL, Rapini RP, editors. Dermatology 2nd ed. India: Elsevier; 2009: 1461-1467.

Bhat YJ, Manzoor S, Qayoom S, Wani R, Baba AN, Bhat AH. Familial reactive perforating collagenosis. Indian J Dermatol. 2009:54;334-7.

Joseph D, Papali C, Pisharody R. Kyrle’s disease: a cutaneous marker of renal disorder. Indian J Dermatol Venereol Leprol 1996; 62: 222–5.

Hicks J, Carpenter CL Jr, Reed RJ. Periumbilical perforating pseudoxanthoma elasticum. Arch Dermatol. 1979;115:300-3.

Cunningham SR, Walsh M, Mathews R, Fulton MB, Burrows D. Kyrle’s disease. J Am Acad Dermatol. 1987;16:117-23.

Morton CA, Henderson IS, Jones MC, Lowe JG. Acquired perforating dermatosis in a British dialysis population. Br J Dermatol. 1996;135:671-7.

Kazakis AM, Parish WR. Periumbilical perforating pseudoxanthoma elasticum. J Am Acad Dermatol. 1988;19:384-8.

Kacchawa D, Kalla G, Bhushan Bharat Dingra, Familial giant reactive perforating collagenosis. Indian J Dermatol. 1993;59:17-8.

Patterson JW, Graff GE, Eubanks SW. Perforating folliculitis and psoriasis. J Am Acad Dermatol. 1982;7:369-76.

Hong SB, Park JH, Ihm CG, Kim NI. Acquired perforating dermatosis in patients with chronic renal failure and diabetes mellitus. J Korean Med Sci. 2004;19:283-8.

Patterson JW. The perforating disorders. J Am Acad Dermatol. 1984;10:561-81.

Patterson JW, Brown PC. Ultrastructural changes in acquired perforating dermatosis. Int J Dermatol. 1992;31:201-5.

Kang BS, Kang H, Kim HO, Park YMl. Three cases of acquired reactive perforating collagenosis. Korean J Dermatol. 1997;35:204-8.

Kalla G, Kachhawa D, Goyal MA, Mathur D. Kyrle’s disease. Indian J Dermatol Venereol Leprol. 1995;61:383-4.